Log in


Log in


National Cancer Institute’s (NCI) CPTAC Research Survey

28 Feb 2019 4:44 PM | Anonymous member (Administrator)

A message from Cabezon Group and Clarivate Analytics

The National Cancer Institute’s (NCI) Office of Cancer Clinical Proteomics Research (OCCPR) has contracted with Cabezon Group and Clarivate Analytics to conduct a third-party, external evaluation which includes a research survey of the external perception of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The survey is designed to be relatively short and should only take approximately 10 to 15 minutes to complete. To complete the survey, please click on

Your strictly voluntary and confidential participation in the survey is vital to our evaluation efforts. The goals of the survey are to examine the impact of CPTAC on the broader field of proteogenomics; how the proteogenomic research community perceives the CPTAC program; and to assess the impact that specific CPTAC program components and actions have had on the research community. Your feedback provides a collaborative, shared understanding of program perceptions which enables improvements intended to benefit future CPTAC activities and impact.

The research results from the evaluation and survey will be disseminated publicly. A summary of the survey results will be placed on the Office of Cancer Clinical Proteomics public website ( In addition, the survey results will be presented at the 2020 annual CPTAC meeting.

You may forward the survey invitation/link to colleagues, but we ask that there is no addition or modification to the invitation message. If you have already completed this survey from another list serve we ask that you do not complete it again.

Thank you for your time and participation.

The Human Proteome Organization is a 501(c)(3) tax exempt non-profit organization registered in the state of New Mexico.  |  © 2021 HUPO

Powered by Wild Apricot Membership Software